Lurasidone for the treatment of bipolar depression: an evidence-based review.

Franklin, Rachel; Zorowitz, Sam; Corse, Andrew K; Widge, Alik S; Deckersbach, Thilo

Franklin, Rachel; Zorowitz, Sam; Corse, Andrew K; Widge, Alik S; Deckersbach, Thilo.

Afiliação

Franklin R; Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Zorowitz S; Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Corse AK; Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Widge AS; Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Deckersbach T; Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.

Neuropsychiatr Dis Treat ; 11: 2143-52, 2015.

Article em En | MEDLINE | ID: mdl-26316760

Palavras-chave

atypical antipsychotic; bipolar depression; bipolar disorder; lurasidone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Neuropsychiatr Dis Treat Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google